Treatment   |   Growth   |   Strategy

 LIVE ONLINE 16 November 2020

Bio Integrates Speakers 2020

STEVE BATES

Chief Executive Officer

UK Bioindustry Association

SEAN MARETT

Chief Business & Commercial Officer

BioNTech

THEO HAROLD

Chief Executive Officer

Crescendo Biologics

CLIVE DIX

Chief Executive Officer

C4X Discovery

STEVE HARRIS

Chief Executive Officer

Circassia

KARIN SCHMITT

Chief Business Officer

Mogrify

IAN CAMPBELL

Interim Executive Chair

Innovate UK

PRIYA MANDE

Chief Operating Officer

PsiOxus Therapeutics

TOBY REID

Chief Executive Officer

BioCity Group

ZUZANNA BRZOSKO

Co-founder and Chief Executive Officer

Sixfold Bioscience

JOHN DAWSON

Chief Executive Officer

Oxford Biomedica

RICHARD WEAVER

Founder and Managing Director

Xenogesis

KEITH THOMPSON

Chair, Pharma Advisory Board

Deep Science Ventures

ZAHID LATIF

Innovation Specialist, Life Sciences Organisation, International Trade & Investment Group

Department for International Trade

KEVIN COX

Chair

ValiRx

JASON MELLAD

Chief Executive Officer

Start Codon

GLENN CROCKER

Head of Life Sciences, JLL & Chairman, BioCity Group

JLL & BioCity Group

SALLY WATERMAN

Chief Operating Officer, Medherant

Sixfold Bioscience

CHRIS TORRANCE

Chief Executive Officer

PhoreMost

BARBARA DOMAYNE-HAYMAN

Entrepreneur-in-residence

Francis Crick Institute

MICHAEL BENNETT

Director of Business Development

Cell and Gene Therapy Catapult

JASON LACOMBE

Chief Executive Officer

Veratrak

DARREN CLARK

Chief Executive

Medilink Midlands

MAUREEN COLEMAN

Chair

CN BioInnovations

ALLAN MARCHINGTON

Managing Partner & Senior Advisor

Bridge Valley Ventures & Apposite Capital

TONY JONES

Chief Executive Officer

One Nucleus

GEOFF DAVISON

Chief Executive Officer

Bionow

SALLY ANN FORSYTH

Chief Executive Officer

Stevenage Bioscience Catalyst

GERALD LAW

Chief Executive

Innovation DB

THOMAS OGORKA

Chief Executive Officer

Orphan Reach

MAIREADH PEDERSEN

Chief Executive Officer

QuayPharma

JESÚS ZURDO

Global Head Bioproduction

Horizon Discovery

EMMA BANKS

Managing Director

ramarketing

RICHARD BUTT

Chief Executive Officer

Apollo Therapeutics

JENNY LAIRD

Vice President, Search & Evaluation Pain & Neurodegeneration

Eli Lilly and Company

JAMES SPICER

Professor of Experimental Cancer Medicine

King’s College London

MARK LEES

Vice President – Corporate Strategy and Operations

Mestag Therapeutics

NICOLA HERON

Head of Collaborative R&D

Medicines Discovery Catapult

DANIEL SMITH

Chief Scientific Officer & Industry Professor, School of Life Science

Cobra Biologics & University of Warwick

CLAIRE THOMPSON

Chief Executive Officer

Agility Life Sciences

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

TERESA LAVOIE

Principal

Fish & Richardson

JOANNA GOULD

Chief Executive Officer and Co-founder

VisusNano

MAYER SCHREIBER

Chief Executive Officer

Discovery Park

JO CRAIG

Senior Vice President CMC

KaNDy Therapeutics & NeRRe Therapeutics

ELISABETH GOODMAN

Owner and Principal Consultant

RiverRhee Consulting

FAZ CHOWDHURY

Chairman and Chief Executive Officer

Nemaura

PAUL STOTT

Chief Executive Officer

Seda Pharmaceutical Development Services

EDDY LITTLER

Chief Operating Officer

ReViral

NICK JOHNSON

Commercial Director

Centre for Process Innovation

STEPHEN TOOKER

Vice President, Commercial Packaging – Europe

PCI Pharma Services

DEREK JONES

Chief Executive Officer

Seda Pharmaceutical Development Services

KATH MACKAY

Managing Director

Alderley Park

JOE DE SOUSA

Senior Leader, Non-Exec Director and Independent Consultant

Melhor Consulting

NEIL HAWKINS

Partner & Director | Professor of Health Technology Assessment

Visible Analytics | University of Glasgow

ROS HANNEN

Chief Executive Officer

Keratify

FLIC GABBAY

Managing Partner

tranScrip

BEVERLEY CARR

Chief Business Officer

Achilles

DECLAN JONES

Vice President and Head of External Innovation (EI) and Scientific Licensing

Ferring Research Institute

DETLEF BEHRENS

Managing Director

Bay Pharma

EUAN CAMERON

Chief Executive Officer & Founder

COHESION Medical

ALLAN JORDAN

Director of Oncology Drug Discovery

Sygnature Discovery

EDDIE BLAIR

Chairman

Virokine Therapeutics

LAURA ITZHAKI

Chief Scientific Officer

PolyProx Therapeutics

MIKE SNOWDEN

Senior Vice President Discovery Sciences, Biopharmaceuticals R&D

AstraZeneca

CLARE TERLOUW

Head of Ventures

LifeArc

CHARLES STEWARD

Patient Advocacy and Engagement Lead

Congenica

JONATHAN APPLEBY

Chief Scientific Officer

Cell and Gene Therapy Catapult (CGT Catapult)

DOUG CUFF

Vice President of U.K. Real Estate

IQHQ

KARL KEEGAN

Chief Executive Officer, Non-Executive Director

Hox Therapeutics Ltd, Nuformix Plc and Novai Ltd.

CHRISTOPHE MULLER

Global Head, Business Development

Evotec (UK) Ltd

RICHARD HEBDON

Head of Health & Medicine, Ageing Society, Health & Nutrition Sector

Innovate UK

HELEN BARKER

Head of Pharmaceutical Development

Reneo Pharma

ROGER KILBURN

Chief Executive Officer

Arcinova

Valued silver sponsors 

Treatment   |   Growth   |   Strategy

 LIVE ONLINE 16 November 2020